🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Indocyanine Green (ICG) is a dye which fluoresces under near-infrared (NIR)...
Status
Completed
Location
Birmingham children's hospital
Start Date
2023-02-01
Trial ID
NCT05735977
Treatments Being Tested
This research study is testing whether a weekly medication called tirzepati...
Status
Recruiting
Location
Institut de Recherches Cliniques de Montréal
Start Date
2026-05-19
Trial ID
NCT07284511
A Phase 1, First-In-Human, Randomized, Double-Blind, Placebo-Controlled Mul...
Status
Completed
Location
Nucleus Network Pty Ltd
Start Date
2025-05-29
Trial ID
NCT06981299
Treatments Being Tested
This multicenter, prospective, open-label randomized controlled trial with ...
Status
Not Yet Recruiting
Location
Beijing Tiantan Hospital, Capital Medical University
Start Date
2026-06-01
Trial ID
NCT07557485
Treatments Being Tested
The purpose of this study was to evaluate the reduction of the Abdominal Ao...
Status
Completed
Location
Chiba-Nishi General Hospital
Start Date
2018-10-03
Trial ID
NCT03837704
Treatments Being Tested
The objective of this study is to investigate the feasibility of cervical T...
Status
Completed
Location
Phoenix Children's Hospital
Start Date
2019-05-21
Trial ID
NCT03859336
Treatments Being Tested
The purpose of this study is to evaluate effect of moxifloxacin on QT/QTc i...
Status
Completed
Location
Seoul National University Hospital
Start Date
2013-01
Trial ID
NCT01756521
Treatments Being Tested
The main purpose of this study to determine the safety of an experimental m...
Status
Completed
Location
Memorial Sloan Kettering Cancer Center
Start Date
2017-01-19
Trial ID
NCT03030885
Treatments Being Tested
The goal of the study is to evaluate strategies that target the microbiota ...
Status
Completed
Location
The Children's Hospital of Philadelphia
Start Date
2015-09-01
Trial ID
NCT02345733
Treatments Being Tested
Atomoxetine (Strattera) is a drug that is currently approved for treatment ...
Status
Completed
Location
Johns Hopkins Hospital
Start Date
2005-01-06
Trial ID
NCT00286949
Treatments Being Tested